Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple negative breast cancer (TNBC) – Results from GeparSixto Gunte

Source URL: www.germanbreastgroup.de

• Ribbon symbolism
• Orphan drugs
• Breast cancer
• Triple-negative breast cancer
• Carboplatin
• TNBC
• Bevacizumab
• Johannes Minckwitz
• Chemistry
• Medicine
• Oncology